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Abstract
Background—Neonatal withdrawal syndrome, which is associated most frequently with opioid 
use in pregnancy, is an emerging public health concern, with recent studies documenting an 
increase in the rate of U.S. infants diagnosed.
Purpose—This study examined neonatal withdrawal syndrome diagnosis among Michigan 
infants from 2000 to 2009 and hospital length of stay (LOS) between infants with and without the 
syndrome for a subset of years (2006–2009).
Methods—Michigan live birth records from 2000 to 2009 were linked with hospital discharge 
data to identify infants with neonatal withdrawal syndrome. Linked data were restricted to infants 
born between 2006 and 2009 to examine the difference in hospital LOS between infants with and 
without the syndrome. Multivariable regression models were constructed to examine the adjusted 
impact of syndrome diagnosis on infant LOS and fit using negative binomial distribution. Data 
were analyzed from July 2011 to February 2012.
Results—From 2000 to 2009, the overall birth rate of infants with neonatal withdrawal 
syndrome increased from 41.2 to 289.0 per 100,000 live births (p<0.0001). Among infants born 
from 2006 to 2009, the average hospital LOS for those with the syndrome was between 1.36 (95% 
CI=1.24, 1.49) and 5.75 (95% CI=5.41, 6.10) times longer than for infants without it.
Conclusions—Diagnosis of neonatal withdrawal syndrome increased significantly in Michigan 
with infants who had the syndrome requiring a significantly longer LOS compared to those 
without it.
Introduction
With prescription opioid use among women of reproductive age increasing since the late 
1990s,1,2 concern regarding the effect on the fetus and newborn has grown. Neonatal 
withdrawal syndrome is an emerging public health concern,3–5 with recent studies 
documenting almost a threefold increase in the rate of U.S. infants diagnosed in the past 
decade.6,7 Neonatal withdrawal syndrome risk is greatest with maternal usage of opioids 
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analgesics and heroin4,8; however, prenatal usage of non-narcotic drugs can cause similar 
neonatal withdrawal symptoms.3
Symptoms usually relate to central nervous system irritability and gastrointestinal 
dysfunction such as tremors, irritability, increased muscle tone, and difficulty sleeping.9,10 
Neonatal withdrawal syndrome infants are more likely to be born preterm6; be admitted to a 
neonatal intensive care unit (NICU)11; and need longer hospitalization (measured as length 
of stay [LOS]).4–7 Little information is available that quantifies the additional LOS of 
neonatal withdrawal syndrome infants compared to other infants after controlling for 
maternal and infant factors.6 Therefore, the purpose of the study was to examine withdrawal 
syndrome diagnosis among Michigan infants from 2000 to 2009 and to compare LOS 
between infants with and without withdrawal syndrome for a subset of years (2006–2009). 
Infants with withdrawal syndrome were hypothesized to require a longer LOS than infants 
without withdrawal syndrome, after adjusting for factors affecting LOS.
Methods
Study Population and Data Sources
A retrospective cohort population-based study was conducted using live birth certificate and 
hospital discharge data for infants born to Michigan (resident) mothers. Hospital discharge 
data contained discharge diagnosis records for all Michigan hospitals. Live birth certificate 
data were linked with hospital discharge records by probabilistic, followed by deterministic, 
linkages performed separately for maternal and infant files. Overall, 88.5% of hospital 
discharge newborn records and 99.2% of maternal records are matched with birth certificate 
records (T Le, Michigan Department of Community Health, unpublished observations, 
2005). Maternal hospital discharge records up to 1 year before and after delivery were 
included.
To examine maternal and infant variables related to neonatal withdrawal syndrome, most 
recent years of data were used (2006–2009). For withdrawal syndrome infants, the 
hospitalization with first withdrawal syndrome diagnosis was selected, whereas for infants 
without the syndrome, the first hospitalization was chosen. Hospitalizations for infants with 
transfers only included the first hospitalization. This study was reviewed and approved by 
the Michigan Department of Community Health IRB.
Measures
Live birth certificate records provided the following data: maternal age; race; education; 
number of named parents; tobacco use during pregnancy; Kotelchuck index (inadequate 
defined as <50% of expected prenatal visits12); Caesarean-section delivery; infant year of 
birth; gender; plurality; birthweight (low defined as <2500 g); and estimated gestational 
weeks. Maternal race was used as a proxy for infant’s race; only the mother acknowledged 
on the birth certificate was used as a proxy for social support at home.
Hospital discharge data provided infant LOS (measured in days); NICU usage; and main 
payment source (private insurance, Medicaid, self-pay, other). Infants with withdrawal 
syndrome were identified by any diagnosis of ICD-9-CM13 Code 779.5. Maternal morbidity 
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was defined by discharge diagnoses related to mental illness (ICD-9-CM=290, 293–302, 
306–319, 648.4) and preexisting chronic conditions (ICD-9-CM=240–246, 250, 393–398, 
435, 440–448, 451–459, 648.0–648.1, 648.5–648.6, 745–747; VIG, unpublished 
observations, 2005) from maternal hospitalizations during pregnancy.
Data Analysis
Analyses were conducted from July 2011 to February 2012. Neonatal withdrawal syndrome 
birth rates per 100,000 live births in Michigan from 2000 to 2009 were calculated, with a 
chi-square test performed for linear trend analysis (Epi Info, version 7). Data from the most 
current years, 2006–2009, were used to measure demographic and health outcomes 
differences between infants with and without neonatal withdrawal syndrome using 
percentages (crude rate per 100) and 95% CIs.
Multivariable regression models examined the adjusted impact of withdrawal syndrome 
diagnosis on infant LOS and were fit using negative binomial distribution (SAS, version 
9.2). Candidate covariates were included based on possible association with both withdrawal 
syndrome diagnosis and infant LOS and included: mother’s race; maternal hospitalization 
related to chronic disease and mental illness; Caesarean-section delivery; low birthweight 
(LBW); having only the mother acknowledged on the birth certificate; insurance type; 
inadequate Kotelchuck index; and smoking.14–17
Nonsignificant (p-value ≥0.002) terms (main effects and two-way interaction effects) were 
dropped sequentially from the model in reverse order of significance, commencing with the 
two-way interaction terms and removing collinear variables, until the most parsimonious 
model was obtained. If a two-way interaction term was significant, the main effects included 
in the interaction were retained. The final multivariable regression model included infant 
neonatal withdrawal syndrome and the following covariates: mother’s race (black, white, 
other); maternal hospitalization related to chronic disease and mental illness; Caesarean-
section delivery; LBW; only the mother being acknowledged on the birth certificate; and 
inadequate Kotelchuck index. Neonatal withdrawal syndrome interaction terms included 
maternal hospitalization related to mental illness and LBW. Adjusted incidence rate ratios 
(IRRs) and 95% CIs were calculated.
Results
From 2000 to 2009, a total of 1509 infants were hospitalized with neonatal withdrawal 
syndrome. The syndrome birth rate per 100,000 live births increased during the study 
period, from 41.2 (2000) to 289.0 (2009; p<0.0001). When stratified by race, the increase 
was significant among white but not black infants (data not shown).
A comparison of infant and maternal characteristics and health outcomes for infants with 
and without withdrawal syndrome are shown in Table 1. Neonatal withdrawal syndrome 
infants were more likely to be white and have Medicaid as their hospital payment source. 
Adjusted IRRs of infant LOS for interactions between neonatal withdrawal syndrome status 
and LBW and maternal hospitalization related to mental illness status are shown in Table 2. 
Among infants with normal birthweight and whose mothers were not hospitalized because 
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of mental illness, those with the syndrome had 5.75 times longer LOS than those without it 
(95% CI=5.41, 6.10). Among LBW infants, the LOS for those with the syndrome was 1.36 
times on average longer than for those without it (95% CI=1.24, 1.49), whereas for infants 
with a maternal mental illness hospitalization, the average LOS for syndrome infants was 
4.66 times longer than it was for infants without it (95% CI=4.39, 4.96).
Discussion
Neonatal withdrawal syndrome infants had a significantly longer LOS than infants without 
withdrawal syndrome after adjusting for factors that could affect LOS, consistent with 
previous literature documenting a higher LOS among infants with withdrawal syndrome,4,5,7 
after adjusting for LBW or prematurity.6 The current study is unique by quantifying the 
additional LOS of infants with withdrawal syndrome after adjusting for maternal factors in 
addition to infant factors. Given that infants with withdrawal syndrome are more likely to be 
covered by Medicaid and to require a significantly longer LOS, these findings suggest that 
the majority of the withdrawal syndrome financial burden falls on state and federal 
governmental funding streams.
Withdrawal syndrome birth rates increased significantly among Michigan infants from 2000 
to 2009, consistent with other recent population-based studies.3–7 Among infants with a 
maternal mental illness hospitalization, the average LOS was almost five times longer for 
withdrawal syndrome infants than for infants without withdrawal syndrome. Withdrawal 
syndrome infants with a maternal mental health illness hospitalization may have a longer 
LOS because of the need for a safe discharge plan to be in place before leaving the 
hospital.18
Limitations
Study limitations relate to validity and completeness of vital statistics and hospital discharge 
data. Identifying infants that have withdrawal syndrome by ICD-9-CM coding alone 
underestimates the true birth rate.19 When infants are transferred from one hospital to 
another, hospitalizations are counted as separate visits, thus lowering LOS into two shorter 
stays, suggesting that the study LOS underestimates the true LOS for some infants with the 
syndrome.
Misclassification of iatrogenic withdrawal infants as those with withdrawal syndrome is 
possible, but it appears to be uncommon. A recent study by Patrick et al. found that 
iatrogenic cases comprised less than 5% of all withdrawal syndrome births in their 
nationally representative sample (2000–2009).7 Although the present study cannot identify 
maternal drugs used to treat opioid dependence, differentiation in pharmacologic treatment 
may influence infant’s postneonatal LOS. Although methadone is considered standard 
treatment for opioid dependence during pregnancy,20,21 a recent study found infants of 
mothers treated with buprenorphine had a significantly shorter hospitalization.22
Conclusion
This study examined the increased LOS of neonatal withdrawal syndrome infants compared 
to other infants and adds to the literature by providing an estimate that adjusts for available 
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maternal factors. Additionally, the increasing withdrawal syndrome trend with infants who 
are more likely to be covered by Medicaid suggests a large public financial burden. The 
estimated hospitalization charges in Michigan for infants with the syndrome born between 
2000 and 2009 totaled more than $35 million.
Raising provider awareness is necessary to promote appropriate evaluation and treatment. 
The use of universal screening questions, brief intervention, and referral to treatment23 may 
help target and decrease drug abuse among women of childbearing age. Further research 
linking prescription drug monitoring data with maternal and infant hospital discharge data 
could identify scheduled drugs prescribed during pregnancy.
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Table 1
Comparison of infant and maternal characteristics by neonatal withdrawal syndrome diagnosis, Michigan 
infants, 2006–2009
Infants with neonatal withdrawal 
syndrome (n=935)a
Infants without neonatal withdrawal 
syndrome (n=470,329)a
% (95% CI) Count % (95% CI) Count
Infant demographics
 Male 55.4 (50.7, 60.4) 518 51.2 (51.0, 51.4) 240,858
 White 83.9 (78.1, 90.0) 780 76.1 (75.9, 76.4) 356,737
 Black 13.7 (11.4, 16.2) 127 18.5 (18.4, 18.6) 86,724
 Other race 2.5 (1.6, 3.7) 23 5.4 (5.29, 5.42) 25,093
 Medicaid hospital payment source 78.5 (72.9, 84.4) 732 42.3 (42.2, 42.5) 198,341
Delivery/infant outcomes
 Mode of delivery Caesarean-section 37.0 (33.1, 41.2) 331 31.4 (31.3, 31.6) 140,669
 Low birthweight (<2500 g) 23.2 (20.2, 26.5) 215 8.0 (7.96, 8.12) 37,648
 Premature (<37 weeks) 24.5 (21.5, 27.9) 228 10.3 (10.2, 10.4) 48,121
 Small for gestational age (<10th percentile) 15.9 (13.4, 18.7) 146 4.8 (4.7, 4.9) 22,096
 NICU admission 29.6 (25.7, 33.9) 204 5.9 (5.8, 6.0) 19,969
Maternal demographics
 <High school graduate 29.1 (25.7, 32.9) 256 16.5 (16.3, 16.6) 72,895
 Age at delivery <21 years 7.9 (6.2, 9.9) 73 14.5 (14.4, 14.6) 68,277
 Only mother acknowledged on birth certificate 34.2 (30.6, 38.2) 320 15.4 (15.3, 15.6) 72,583
Maternal health variables
 Inadequate Kotelchuck index 35.8 (32.0, 40.0) 315 11.4 (11.35, 11.55) 51,551
 Smoking during pregnancy 69.6 (64.4, 75.3) 640 17.5 (17.3, 17.6) 81,771
 Chronic disease–related hospitalization 6.6 (5.1, 8.5) 62 4.8 (4.7, 4.9) 22,582
 Mental illness–related hospitalization 50.7 (46.2, 55.5) 473 6.4 (6.3, 6.5) 30,097
a
In all calculations for percentages, missing values were excluded from the calculation in both the numerator and denominator. NICU, neonatal 
intensive care unit.
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Table 2
IRRs (95% CIs) of infant hospital length of stay for interactions terms, for infants with neonatal withdrawal 
syndrome, Michigan, 2006–2009
Unadjusted Adjusteda
Low birthweight
 Yes 1.13 (1.04, 1.23) 1.36 (1.24, 1.49)
 No 5.27 (5.04, 5.52) 5.75 (5.41, 6.10)
Maternal hospitalization related to mental illness
 Yes 2.73 (2.52, 2.95) 4.66 (4.39, 4.96)
 No 4.21 (3.90, 4.55) 5.75 (5.41, 6.10)
Note: N=426,030. The referent is infants without neonatal withdrawal syndrome.
aAdjusted for mother’s race (black, white, other); maternal hospitalization related to chronic disease; maternal hospitalization related to mental 
illness; Caesarean-section delivery; low birthweight; inadequate Kotelchuck index; and having only the mother acknowledged on birth certificate.
IRR, incidence rate ratio.
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